Welcome to our dedicated page for High Tide news (Ticker: HITI), a resource for investors and traders seeking the latest updates and insights on High Tide stock.
High Tide Inc. (HITI) maintains its position as Canada's leading vertically integrated cannabis retailer through continuous innovation in retail operations and e-commerce solutions. This news hub provides investors and industry observers with essential updates on corporate developments, financial milestones, and strategic initiatives within the evolving cannabis market.
Access authoritative information about HITI's retail expansions, technology implementations like the Fastendr kiosk system, and quarterly performance metrics. Our curated collection features official press releases covering earnings announcements, partnership agreements, product launches, and regulatory compliance updates.
Key focus areas include Canna Cabana store network growth, cannabis accessory innovations, and operational efficiency improvements. Users can track the company's progress in enhancing customer experiences through both physical retail locations and digital platforms while monitoring its competitive positioning within North American markets.
Bookmark this page for streamlined access to verified information about High Tide's business strategies, leadership decisions, and market responses. Regular updates ensure you maintain current awareness of developments affecting this dynamic cannabis enterprise.
High Tide (Nasdaq: HITI) recapped 2025 milestones including domestic expansion and international entry into Germany via a majority stake in Remexian Pharma.
Key metrics: an annualized revenue run-rate of $600M (pre-Remexian), an annualized Adjusted EBITDA run-rate of over $42M, same-store sales +7.4% in Q3 2025, retail sales per square foot of $1,735 in Q3 2025, 218 Canna Cabana stores, ~2.4M Cabana Club members (including 139,000 ELITE), +27 new stores in 2025, and a 12% market share across five Canadian provinces.
High Tide (Nasdaq: HITI) will participate in the ICR Conference in Orlando, Florida, hosting two days of meetings with institutional investors and a public fireside chat. The fireside chat features Raj Grover, Founder and CEO, moderated by Bill Kirk of ROTH Capital Partners, scheduled for 8:00 a.m. EST on Tuesday, January 13, 2026. The company said the conference is an opportunity to showcase its retail-focused platform and recent momentum following a record 2025.
High Tide describes its retail brand Canna Cabana as a major asset (218 Canadian and 1 international location) and highlights medical distribution via Remexian in Germany and other corporate recognitions through 2025.
High Tide (Nasdaq: HITI) welcomed a White House Executive Order advancing cannabis rescheduling and an announced CMS pilot to allow certain Medicare beneficiaries to receive CBD treatments at no cost, dated Dec 18, 2025. The company said its U.S. CBD brands, NuLeaf Naturals and FAB CBD, will evaluate Medicare-aligned product categories and that it is assessing U.S. licensing pathways to expand its Canna Cabana retail brand while maintaining NASDAQ and TSXV compliance.
The company reengaged an IR agency effective Dec 19, 2025 at a fee of USD $140,000 per month on a fee-for-service basis.
High Tide (Nasdaq: HITI) will open three new Canna Cabana stores in London, Brampton and Calgary, bringing its Canadian Canna Cabana network to 218 locations (91 in Alberta, 94 in Ontario).
The London store aims to begin sales on Dec 15, 2025, Brampton on Dec 20, 2025 and Calgary on Dec 23, 2025, each pending regulatory approval. Management said these openings put the company at the upper end of its goal to open 20–30 new locations this year. A Berlin Canna Cabana is temporarily closed while an operational matter is addressed.
High Tide (Nasdaq: HITI) opened its first European Canna Cabana flagship store in Berlin on December 1, 2025, marking its bricks-and-mortar entry into Germany and Europe.
The store at Alte Schönhauser Str. 2 sits in Berlin-Mitte near Alexanderplatz. The launch follows High Tide's acquisition of Remexian Pharma GmbH, a licensed German medical cannabis importer and distributor, and supports a multi-channel European strategy across retail, e-commerce, and medical distribution.
Key disclosed metrics: 215 domestic Canna Cabana locations, 1 international location, a reported 12% Canadian market share, Remexian licensed to import from 19 countries, and German imports of 143 tonnes in the first three quarters of 2025.
High Tide (Nasdaq: HITI) announced four new Canna Cabana store openings in Calgary, Scarborough, Kitchener, and Nepean, bringing its national retail footprint to 215 Canna Cabana locations across Canada with 90 in Alberta and 92 in Ontario. The Calgary store opens Nov 13, 2025; Scarborough Nov 17; Kitchener Nov 18; Nepean Nov 20.
The company said it has opened 24 new locations year-to-date and remains on track toward the higher end of its 20–30 new-store target for 2025. High Tide also granted 61,000 incentive stock options to employees (3-year term, 2-year vest).
High Tide (Nasdaq: HITI) will open a new Canna Cabana retail store at 518 Centennial Pkwy North in Hamilton, Ontario, beginning sales of recreational cannabis and consumption accessories on October 27, 2025.
The addition brings Canna Cabana to 211 locations nationwide and 89 stores in Ontario. The store sits in a high-traffic commercial centre near the QEW with an estimated resident population of ~47,000 within three kilometres, positioned to serve local and commuter demand.
The announcement highlights High Tide's retail expansion and continued focus on growing its Canna Cabana footprint in Ontario.
High Tide (Nasdaq: HITI) celebrates four years of its Cabana Club loyalty program and raised long-term targets to 3.0 million Cabana Club members and 350 Canna Cabana locations across Canada (up from 2.2M members and 210 locations as of Oct 21, 2025).
The company reports Cabana Club membership grew 800% since launch and now drives >90% of in-store sales; ELITE paid members total 120,000. Canna Cabana holds a 12% market share in its five-province footprint; national retail cannabis sales were $5.5B for the 12 months ending July 2025.
High Tide Inc. (NASDAQ: HITI) has secured the 182nd position among 400 companies in the 2025 Report on Business ranking of Canada's Top Growing Companies, achieving a three-year revenue growth rate of 188%. This marks the company's fifth consecutive year on the prestigious list, following their 2024 ranking of 87th with a 486% growth rate.
The cannabis retail enterprise has expanded significantly, with its subsidiary Canna Cabana operating 210 locations across Canada and commanding a 12% market share. The company recently completed a majority acquisition of Remexian Pharma GmbH, a German pharmaceutical company licensed to import medical cannabis from 19 countries, marking High Tide's strategic entry into Europe's largest cannabis market.
High Tide continues to receive recognition for its growth, including rankings on the TSX Venture Exchange's top 50 companies and the Financial Times' list of Americas' Fastest Growing Companies.
High Tide Inc. (NASDAQ: HITI) announced the opening of three new Canna Cabana retail locations in North York, Etobicoke, and Fort McMurray. The expansion brings the company's total store count to 210 locations across Canada, with 89 in Alberta and 88 in Ontario.
The new stores will open between September 26-29, 2025, strategically positioned in high-traffic areas. High Tide is maintaining its growth strategy of opening 2-3 new locations monthly, funded entirely through internal profits without external capital. The company currently holds a 12% market share in Canada and has been recognized as one of Canada's Top Growing Companies for four consecutive years.
FAQ
What is the current stock price of High Tide (HITI)?
What is the market cap of High Tide (HITI)?
